Page 33 - Roche Hemlibra Non-inhibitors - Product Monograph

10. REFERENCES

01. Callaghan M, et al. ISTH 2019; oral presentation OC 60.2
02. Cassis F. Psychosocial care for people with hemophilia. World Federation of Hemophilia 2007. Available at:
http://www1.wfh.org/publication/files/pdf 1198.pdf. Accessed on 12 April 2017.
03. Castaman G et al. Expert Rev Hematol 2018;11(7):567−76.
04. Data & Statistics. Hemophilia. NCBDDD. CDC. Centers for Disease Control and Prevention.
https://www.cdc.gov/ncbddd/hemophilia/data.html. Published 2021. Accessed January 12, 2021.
05. Dekoven M et al. Haemophilia 2013;19(2):287−93.
06. Dekoven M et al. Haemophilia 2014;20(6):822−30.
07. Elocta® SmPC
08. F. Hoffmann-La Roche Ltd: Roche reports a strong start in 2019 and raises the outlook for the full-year. Bloomberg.com.
Accessed on August 17, 2020.
09. Forsyth AL et al. Patient Prefer Adherence 2015;9:1549−60.
10. Genentech: Press Releases, 2019. Available at:
https://www.gene.com/media/press-releases/14800/2019-07-08/genentech-presents-a-broad-range-of-data. Accessed
on August 17, 2020.
11. Giangrande P et al. Thromb Haemost 2017;117(2):252−61.
12. Gringeri A et al. Haemophilia 2013;19(5):736−43.
13. Guh S et al. Haemophilia 2012a;18(2):268−75.
14. Guillon P et al. Haemophilia 2015;21(1):21−6.
15. Hacker MR et al. Haemophilia 2001;7(4):392−6.
16. HEMLIBRA® SmPC
17. Jiménez-Yuste V, et al. Preference for Emicizumab over Prior Factor Treatments: Results from the HAVEN 3 and HAVEN 4
Studies. Blood. 2018;132 (1): 1187. https://doi.org/10.1182/blood-2018-99-118132
18. Khair K et al. Haemophilia 2018;24(1):85−96.
19. Khair K et al. J Haem Pract 2017;4(1).
20. Khair K et al. J Haem Pract 2017;4(1).
21. Kitazawa T et al. Int J Hematol. 2020 Jan;111(1):20-30.
22. Kitazawa T et al. Thromb Haemost. 2017;117(7):1348-1357. doi:10.1160/TH17-01-0030
23. Kloosterman F et al Res Pract Thromb Haemost. 2020 Feb 28;4(3):377-385. doi: 10.1002/rth2.12314. PMID: 32211572;
PMCID: PMC7086468.
24. Konkle BA et al. Blood 2015;126(9):1078−85.
25. Kraft J et al. J Thromb Haemost 2012;10(12):2494−502.
26. Kruse-Jarres R et al. Haemophilia. 2019 Mar;25(2):213-220
27. Mahlangu J et al. Blood 2014;123(3):317−25.
28. Mahlangu J, et al. N Engl J Med 2018;379:811–22
29. Mullins ES et al. Haemophilia 2017;23(2):238−46.
30. Oldenburg J, et al. N Engl J Med 2017;377:809–18
31. Olivieri M et al. Haemophilia 2012;18(3):369−74.
32. Pipe S, et al. Lancet Haematol 2019;6:e295–e305
33. Pollmann H et al. Ann Hematol 2013;92(5):689−98.
34. Poon JL et al. Haemophilia 2012;18(5):699−707.

HEMLIBRA Monograph-Non-inhibitors | 31
®